Allscripts Healthcare Solutions, Inc. changed its name to Veradigm Inc. As of January 1, 2023, Allscripts is now known as Veradigm.
Allscripts transitioned its solutions to the Veradigm commercial brand.
For the 2nd year in a row, Pulse8 is excited to announce our Qualit8™ solution has received NCQA Certification for HEDIS® MY 2021.
Veradigm has announced a strategic partnership with Juxly to help bring integrated, risk, quality and value-based care gap messaging to the point of care.
Veradigm partners with PRA Health Sciences (now ICON) to create the industry’s leading EHR-based clinical research network
Veradigm is a research partner for the COVID-19 Patient Recovery Alliance, a multi-sector collaboration to support patients with long-term health consequences from COVID-19 infection.
Practice Fusion reimagines phenomenal customer support to better serve small, independent practices.
Pulse8 is excited to announce our new Qualit8™ Platinum solution has received full NCQA Certification for HEDIS® MY 2020
Deepening our partnership with NextGen Healthcare to enable Veradigm AccelRx integration within NextGen Enterprise EHR by mid-2022.
Practice Fusion adds Care Innovations as a partner to provide remote patient monitoring services to independent practices.
Announced partnership between Veradigm and AmerisourceBergen’s LASH Group specialty medication hub to support Veradigm AccelRx.
Debuted Veradigm TouchPoint Media solution name for Veradigm’s leading - point-of-care media solutions offering.
HealthMine and Pulse8 Form Strategic Partnership to Improve Health Plan Performance and Member Experience
Veradigm is a member of the Decentralized Trials & Research Alliance which enables the collaboration of stakeholders to accelerate the adoption of patient-focused, decentralized clinical trials.
Announced partnership between Veradigm and HealthVerity to expanding linking real-world data to clinical trial data and therapeutic area data.
Partnered with leading non-profit PAN Foundation to deliver targeted messages direct to clinicians within their EHR to help reduce patients’ out-of-pocket costs for medication.
Launched Veradigm AccelRx, a unique, all-in-one specialty medication fulfillment platform designed to help cut time-to-fill for specialty drugs.
Veradigm is a member of the COVID-19 Healthcare Coalition, working to enable sharing of outcomes and analytics on therapeutic effectiveness and reinfection rates
Payerpath with its large provider base joined Veradigm and the Payer Business Unit.
Veradigm is a founding member of a consortium of leading healthcare companies who are pooling data to form the COVID-19 Research Database.
Released Medication Adherence Report on observed impact of Veradigm RxTruePrice™ on medication adherence among users.
Partnership with Updox announced by Practice Fusion, a brand of Veradigm, to offer telehealth, appointment reminders and patient engagement communication tools.
First annual Survey of Independent Practices results announced by Practice Fusion, a brand of Veradigm.
Komodo Health partnership linked more than 50 million patient records with real-world EHR-based data and claims information.
Partnered with American College of Cardiology to develop nextgeneration research network: NCDR PINNACLE and Diabetes Collaborative Registries.
Acquired ZappRx, a leading specialty medication fulfillment platform.
New Research Network Model—Research at the Point-of-Care is introduced by Stephanie Reisinger, Life Science General Manager, and featured speaker at Eye4Pharma.
Released Medication Affordability Report on observed impact of price transparency technology on patients and providers.
Acquired new U.S. patent for Electronic Prior Authorization Systems and Methodologies.
Agreement with NextGen® Healthcare to streamline healthcare provider workflow and facilitate data sharing.
Veradigm becomes the largest source of de-identified ambulatory patient records available.
Debut at HIMSS 2019, co-presenting with Surescripts on price transparency in the Interoperability Showcase.
The Whitepaper Payer-Provider Interoperability and Value Model Adoption, produced in partnership with Xtelligent Media was released by Pulse8, in collaboration with Veradigm.
Released ePrecribing Regulations Report detailing how legislative and regulatory standards are affecting stakeholders.
Acquired new U.S. patent on Facilitating Prescription Management.
Top 10 award for poster Characteristics of Migraine Patients with Migraine Disability Assessment (MIDAS) Scores in Real-world Clinical Practice at ISPOR conference.
Recognized by Healthcare Ready for work in enabling access to patient medical history in wake of Hurricane Harvey.
Pulse8 added to the Veradigm portfolio to strengthen the health plan product suite.
Pulse8 debuts significant enhancements to its Illumin8 Active Intelligence™ solution suite, most notably an ACO-specific module to their flagship risk adjustment solution and the implementation of Pulse Alerts.
Microsoft partnership to develop an EHR-agnostic platform that brings research capabilities directly into point-of-care workflows.
Veradigm and Surescripts announced initial study results of Price Transparency at the Point of Care Boosts Patient Savings and Prescriber Efficiency.